Topical Fluorometholone Versus Diclofenac Sodium in Cases With Perennial Allergic Conjunctivitis. 2015

Zhiwei Li, and Wei Chen, and Yong Zhang, and Vishal Jhanji, and Zhaoshan Fan, and Guoying Mu
Department of Ophthalmology (Z.L., Y.Z., Z.F., G.M.), Provincial Hospital, Shandong University, Ji'nan, China; Tian'Jin Eye Hospital (W.C.), Tianjin, China; and Department of Visual Sciences and Ophthalmology (V.J.), The Chinese University of Hong Kong, Hong Kong, China.

OBJECTIVE To compare the efficacy of diclofenac sodium (DS) 0.1% and fluorometholone (FL) 0.1% in patients with perennial allergic conjunctivitis. METHODS Fluorometholone 0.1% or DS 0.1% eye drops were topically administrated 4 times daily for 4 weeks in patients with perennial allergic conjunctivitis. Assessment was conducted with a 4-point rating scale (0=none, 1=mild, 2=moderate, and 3=severe) for 4 signs and 5 symptoms. RESULTS Two hundred sixty-one patients were recruited. The demographics and baseline skin prick scores between both groups were comparable. Mean baseline scores in DS and FL group were 6.77 ± 2.24 and 6.34 ± 2.10, respectively. The scores rapidly decreased to 3.28 ± 1.47 and 2.69 ± 1.44 on day 7. Diclofenac sodium expressed a slower effect compared with FL within the first 3 days of treatment (P=0.01). CONCLUSIONS The efficacy of topical FL and DS was comparable for the management of cases with perennial allergic conjunctivitis. However, FL led to a more rapid alleviation of signs and symptoms as compared with DS in early days after the initiation of treatment.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009883 Ophthalmic Solutions Sterile solutions that are intended for instillation into the eye. It does not include solutions for cleaning eyeglasses or CONTACT LENS SOLUTIONS. Eye Drop,Eyedrop,Eyedrops,Ophthalmic Solution,Eye Drops,Drop, Eye,Drops, Eye,Solution, Ophthalmic,Solutions, Ophthalmic
D003233 Conjunctivitis, Allergic Conjunctivitis due to hypersensitivity to various allergens. Allergic Conjunctivitis,Conjunctivitis, Atopic,Conjunctivitis, Giant Papillary,Conjunctivitis, Vernal,Keratoconjunctivitis, Vernal,Allergic Conjunctivitides,Atopic Conjunctivitides,Atopic Conjunctivitis,Conjunctivitides, Allergic,Conjunctivitides, Atopic,Conjunctivitides, Giant Papillary,Conjunctivitides, Vernal,Giant Papillary Conjunctivitides,Giant Papillary Conjunctivitis,Keratoconjunctivitides, Vernal,Papillary Conjunctivitides, Giant,Papillary Conjunctivitis, Giant,Vernal Conjunctivitides,Vernal Conjunctivitis,Vernal Keratoconjunctivitides,Vernal Keratoconjunctivitis
D004008 Diclofenac A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt. Diclophenac,Dichlofenal,Diclofenac Potassium,Diclofenac Sodium,Diclonate P,Dicrofenac,Feloran,GP-45,840,Novapirina,Orthofen,Orthophen,Ortofen,SR-38,Sodium Diclofenac,Voltaren,Voltarol,Diclofenac, Sodium,GP 45,840,GP45,840,SR 38,SR38
D005260 Female Females
D005469 Fluorometholone A glucocorticoid employed, usually as eye drops, in the treatment of allergic and inflammatory conditions of the eye. It has also been used topically in the treatment of various skin disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p732) Cortisdin,Efflumidex,FML,FML Forte,FML Liquifilm,Flucon,Fluor-Op,Fluoro-Ophtal,Fluoropos,Isopto Flucon,PMS-Fluorometholone,Flucon, Isopto,Fluor Op,Fluoro Ophtal,PMS Fluorometholone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Zhiwei Li, and Wei Chen, and Yong Zhang, and Vishal Jhanji, and Zhaoshan Fan, and Guoying Mu
January 2003, Current medical research and opinion,
Zhiwei Li, and Wei Chen, and Yong Zhang, and Vishal Jhanji, and Zhaoshan Fan, and Guoying Mu
July 2023, International ophthalmology,
Zhiwei Li, and Wei Chen, and Yong Zhang, and Vishal Jhanji, and Zhaoshan Fan, and Guoying Mu
August 1989, Allergy,
Zhiwei Li, and Wei Chen, and Yong Zhang, and Vishal Jhanji, and Zhaoshan Fan, and Guoying Mu
October 1998, Recenti progressi in medicina,
Zhiwei Li, and Wei Chen, and Yong Zhang, and Vishal Jhanji, and Zhaoshan Fan, and Guoying Mu
January 2022, Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society,
Zhiwei Li, and Wei Chen, and Yong Zhang, and Vishal Jhanji, and Zhaoshan Fan, and Guoying Mu
January 2014, Recent patents on inflammation & allergy drug discovery,
Zhiwei Li, and Wei Chen, and Yong Zhang, and Vishal Jhanji, and Zhaoshan Fan, and Guoying Mu
June 2009, Recent patents on inflammation & allergy drug discovery,
Zhiwei Li, and Wei Chen, and Yong Zhang, and Vishal Jhanji, and Zhaoshan Fan, and Guoying Mu
June 2014, The British journal of ophthalmology,
Zhiwei Li, and Wei Chen, and Yong Zhang, and Vishal Jhanji, and Zhaoshan Fan, and Guoying Mu
January 1986, Transactions of the ophthalmological societies of the United Kingdom,
Zhiwei Li, and Wei Chen, and Yong Zhang, and Vishal Jhanji, and Zhaoshan Fan, and Guoying Mu
June 2015, The Cochrane database of systematic reviews,
Copied contents to your clipboard!